IL28B Alleles Associated With Poor Hepatitis C Virus (HCV) Clearance Protect Against Inflammation and Fibrosis in Patients Infected With Non-1 HCV Genotypes

In chronic hepatitis C, IL28B variants associated with poor response to interferon therapy may predict slower fibrosis progression, especially in patients infected with non-1 HCV genotypes.